Christian R. Kowol - Concepedia

Author

Christian R. Kowol

Also Known As

C. Kowol, C. R. Kowol, C.R. Kowol, Christian R. Kowol, Christian Kowol, Christian R Kowol, Christian R. Kowol, Kowol, C., Kowol, C.R., Kowol, Christian

224

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

University of Vienna Medical University of Vienna Comprehensive Cancer Center Vienna University of Szeged HUN-REN Research Centre for Natural Sciences

About

Christian R. Kowol is an author at University of Vienna specializing in pharmacology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	1.8K
2	Natural Sciences	18	22	1.2K
3	Biochemistry	18	23	1.2K
4	Engineering	13	13	640
5	Health Sciences	1	1	57

Christian R. Kowol

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application Robert Trondl, Petra Heffeter, Christian R. Kowol, Chemical Science Chemoprevention StrategyPharmacotherapyTumor BiologyOncologyClinical Application	2014	652
Impact of Metal Coordination on Cytotoxicity of 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone (Triapine) and Novel Insights into Terminal Dimethylation Christian R. Kowol, Robert Trondl, Petra Heffeter, Journal of Medicinal Chemistry	2009	159
Gallium(III) and Iron(III) Complexes of α-N-Heterocyclic Thiosemicarbazones: Synthesis, Characterization, Cytotoxicity, and Interaction with Ribonucleotide Reductase Christian R. Kowol, Roland Berger, R. Eichinger, Journal of Medicinal Chemistry	2007	151
Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds Christian R. Kowol, Petra Heffeter, Walter Miklos, JBIC Journal of Biological Inorganic Chemistry Medicinal ChemistryMedicineNatural SciencesBioactive MetalRedox Chemistry	2011	146
An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo Josef Mayr, Petra Heffeter, Diana Groza, Chemical Science EngineeringTumor BiologyNanomedicineTheranosticsCancer Cell Biology	2016	127
Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes Michael R. Reithofer, Anna K. Bytzek, Seied M. Valiahdi, Journal of Inorganic Biochemistry Medicinal ChemistryStructural VariationBiochemistryPolymer-drug ConjugateNatural Sciences	2010	122
Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): A combined experimental and theoretical study Ana Popović‐Bijelić, Christian R. Kowol, Maria E. S. Lind, Journal of Inorganic Biochemistry Medicinal ChemistryBiochemistryNatural SciencesMetalloproteinCombined Experimental	2011	120
Preclinical characterization of anticancer gallium(III) complexes: Solubility, stability, lipophilicity and binding to serum proteins Alexander V. Rudnev, Lidia S. Foteeva, Christian R. Kowol, Journal of Inorganic Biochemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesPreclinical Characterization	2006	109
Maleimide-functionalised platinum(iv) complexes as a synthetic platform for targeted drug delivery Verena Pichler, Josef Mayr, Petra Heffeter, Chemical Communications Molecular BiologyClick ChemistryThiol-containing Tumour-targeting MoleculesNanomedicineMedicinal Chemistry	2013	88
Fluorescence properties and cellular distribution of the investigational anticancer drugTriapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and its zinc(ii) complex Christian R. Kowol, Robert Trondl, Vladimir B. Arion, Dalton Transactions Fluorescence MicroscopyEngineeringBiochemistryNovel Imaging MethodCellular Distribution	2009	87

Page 1